User banner image
User avatar
  • admin

Posts

Indonesia’s Supreme Court Urges Lawyers to Uphold Reason, Instinct, and Conscience Amid Growing Legal Complexity

JAKARTA, Indonesia, June 19, 2026 /PRNewswire/ — As global legal complexity intensifies alongside rapid digital transformation and rising international standards, the quality of Indonesia’s legal...

Shop-Vac Introduces a New Generation of Handheld Vacuums Designed for Real Life

WILLIAMSPORT, Pa., June 20, 2026 /PRNewswire/ — Some of life’s best moments also happen to be the messiest. Stylish, Lightweight, and Always Ready for Life’s...

SpeakON Drops Pro Subscription: All AI Features Now Included Free with Hardware Purchase

SpeakON retires its monthly software plan, bundling unlimited AI voice-to-text capabilities into the hardware at no additional cost SAN FRANCISCO, June 20, 2026 /PRNewswire/ —...

Laifen Announces Prime Day Savings on Award-Winning Hair, Oral Care and Grooming Innovations

Consumers can shop major discounts on viral hair dryers, electric toothbrushes, electric shavers and more during Amazon’s biggest shopping event of the year. NEW YORK,...

Futurpreneur announces Canada’s 2026 delegation to the G20 Young Entrepreneurs’ Alliance Summit in Vienna, Austria 

TORONTO, June 19, 2026 (GLOBE NEWSWIRE) — Forty young entrepreneurs from across Canada are preparing to bring Canadian innovation, ambition and global growth potential to...

Arletta Pharma Solutions Appoints Steve van Os, MD, as Chief Medical Officer

www.arlettapharmasolutions.com Seasoned biotech executive brings more than two decades of global clinical development, medical affairs and regulatory leadership across oncology, women’s health and endocrinology Appointment...

Glass House Brands Announces Voting Results Following Annual Meeting

LONG BEACH, Calif. and TORONTO, June 19, 2026 (GLOBE NEWSWIRE) — Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U) (OTCQX: GLASF)...

uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy

~ AMT-260 was generally well-tolerated with no serious adverse events observed to date, with early biological signals of potential therapeutic activity ~ LEXINGTON, Mass. and...

Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma

Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma Approval based on multiple studies, including the pivotal IRAKLIA phase 3 study which...

Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026

Global CRO expands its operational footprint into Singapore and Malaysia, strengthens China presence, and grows India operations – creating a powerhouse in the Asia Pacific...